Table 3.

Study variables and assessment points

Instrument	Assessment area	Time of assessment
MINI Neuropsychiatric	Psychiatric diagnosis	Baseline, Post-T and follow-ups
Interview
BAI	Severity of anxiety	Baseline, Post-T and follow-ups
BDI-II	Severity of depression	Baseline, Post-T and follow-ups
Sociodemographic data	Gender, age, marital status, education, occupation, economic level	Baseline
OASIS	Severity of anxiety	Post-module
ODSIS	Severity of depression	Post-module
SIAS	Severity of SAD symptoms	Baseline, Post-T and follow-ups
PDSS-SR	Severity of PD and agoraphobia symptoms	Baseline, Post-T and follow-ups
PSWQ	Severity of GAD symptoms	Baseline, Post-T and follow-ups
OCI-R	Severity of OCD symptoms	Baseline, Post-T and follow-ups
EQ-5D	Health-related quality of life	Baseline, Post-T and follow-ups
PANAS	Positive and negative affect	Post-module
BIS-BAS	Behavioral inhibition/activation	Baseline, Post-T and follow-ups
ETS	Expectation of treatment	Baseline
OTS	Opinion of treatment	Post-T

Post-T, post-treatment (18 weeks after baseline); follow-ups, 3- and 12-month follow-ups. BAI, Beck Anxiety Inventory; BDI-II, Beck Depression Inventory-II; OASIS, Overall Anxiety Severity and Impairment Scale; ODSIS, Overall Depression Severity and Impairment Scale; SIAS, Social Interaction Anxiety Scale; PDSS-SR, Self-Reported Panic Disorder Severity Scale; PSWQ, Penn State Worry Questionnaire; OCI-R, Obsessive-Compulsive Inventory-Revised; EQ-5D, EuroQoL-5D questionnaire PANAS, Positive and Negative Affect Scale; BIS-BAS, Behavioral Inhibition and Behavioral Activation Scales; ETS, Expectation of Treatment Scale; OTS, Opinion of Treatment Scale